Independent Cost Containment · Est. 2013

Your employees get the same care.
Your plan pays less.

Sigma Global restates the largest uncontrolled line item in your benefits budget — specialty medications — and returns the difference to your organization. Performance-based. Documented. Built for board-level review.

The Line Item

One line in your budget is growing faster than everything else.

If your organization is self-insured, specialty medications are almost certainly your fastest-growing benefits cost — and the least examined. Three numbers explain why this deserves a seat at your next budget review.

~2%
of members

Fewer than two in a hundred covered members use specialty medications. The exposure is concentrated — which means it is addressable.

~50%+
of pharmacy spend

That same small group drives roughly half of total pharmacy cost — biologics, specialty respiratory therapies, and GLP-1s leading the way.

10.5%
of total claims are now GLP-1s

GLP-1 medications alone now represent over a tenth of annual claims for the average employer plan — up from under 7% two years ago, and still accelerating.

Sources: industry claims benchmarks; IFEBP employer survey data, 2025. Your verified figures replace these in your analysis.

The Ledger

The same line item, restated.

Sigma Global sources the brand-name specialty medications already in your plan through a licensed Canadian pharmacy partner — at a structurally lower price for the identical product. Nothing about the care changes. Only the cost basis does.

Line item Today Restated
GLP-1 medicationsOzempic, Mounjaro, Wegovy & comparable therapies U.S. wholesale materially lower
Biologic injectablesAutoimmune & inflammatory conditions U.S. wholesale materially lower
Specialty respiratory biologicsSevere & treatment-resistant asthma U.S. wholesale materially lower
Medication, manufacturer, prescriberThe clinical picture unchanged unchanged
Bottom line to your budget status quo the majority returned to you
Exact figures produced from your population in 48 hours Verified monthly · dispensing-record level
Directional Estimate

What scale are we talking about?

Move the slider to your covered population. The range below is a directional estimate built on published per-covered-life specialty benchmarks — your verified number comes from your actual medications.

Covered lives — employees + dependents
250covered lives
501,0002,000
Estimated annual budget recovery
$63,000$130,000

Returned to your organization each year, after Sigma Global's performance fee. From spend you are already committed to, on medications your members already take.

Directional only — assumes published specialty-spend benchmarks per covered life and typical medication mix. Verified analysis from your data in 48 hours.

Who It's For

Built for the two people who own this decision.

For the CFO

A line item that finally moves.

  • 01Zero upfront cost. Our fee is a share of verified savings only — calculated on dispensing records, never projections. If we don't produce savings, we are not paid.
  • 02Budget recovery, not budget cutting. The savings come from restating the cost basis of existing spend — no service reduction, no benefit cuts, no headcount conversation.
  • 03Defensible in any room. Compliance documentation suitable for legal counsel, plan auditors, and stop-loss carriers is provided before a single member enrolls.
  • 04Monthly verification. Drug-by-drug, member-by-member savings reports — board-presentable, reconcilable against the plan's own records.
For the CHRO

Nothing changes for your people.

  • 01The same medication. Brand-name, same manufacturer, same formulation. No generic substitution, no compounded alternatives, no formulary surprises.
  • 02The same prescriber. Members keep their doctor and their existing prescription. A licensed pharmacist reviews every order before it ships.
  • 03Delivered to their door. Cold-chain packaging on every temperature-sensitive order, tracking on every shipment, typically within 3 business days.
  • 04Voluntary by design. Members opt in. Nothing is taken away from anyone — the program adds a lower-cost path for those who choose it.
Process

From first look to verified savings in under 30 days.

Step 01

Savings analysis

Send your covered population and top specialty medications — or claims data if you have it. We return a documented, drug-by-drug analysis.

48 hours · no commitment
Step 02

Legal & compliance review

Your counsel receives the full documentation package — licensing, dispensing records, cold-chain protocol, regulatory framework — before anything launches.

Provided at onboarding
Step 03

Member enrollment

Eligible members opt in through a secure portal. A licensed pharmacist reviews every prescription. First orders ship within days.

Typically 3 business days to first delivery
Step 04

Monthly verification

Savings verified against dispensing records and reported monthly. Our fee is calculated only on what is documented.

Ongoing · board-presentable
Governance

Built to survive scrutiny.

Any program can promise savings. The question your counsel, your auditor, and your stop-loss carrier will ask is whether the program behind the number holds up. Ours was built for that question.

Licensed sourcing, one jurisdiction

We source exclusively through a licensed Canadian pharmacy partner in Manitoba — the only Canadian province whose regulator specifically authorizes international prescription fulfillment. One pathway, fully documented, no exceptions for price.

An established federal framework

Personal importation from licensed Canadian pharmacies operates under FDA enforcement discretion — a framework with more than twenty years of documented precedent. Every order satisfies its conditions.

Records on every order

Each dispensing record carries 19 documented fields — pharmacist license, drug identification matched to U.S. coding, lot number, expiry — retained for seven years and available to plan sponsors on request.

Hard structural limits

No compounded medications. No controlled substances. No sourcing outside Canada regardless of price. No order without a valid prescription reviewed by a licensed pharmacist. The boundaries are the program.

The Fee Model

We are paid from results. Only.

$0
Upfront & out of pocket

No retainers, no implementation fees, no per-member charges, no cost to launch. The program funds itself entirely from the savings it produces.

Share
of savings
Our entire compensation

Sigma Global earns an agreed share of verified savings — and nothing else. The structure is set with you up front, the majority of every dollar stays with your plan, and if verified savings are zero, our fee is zero.

Performance-based by design — we are paid only after your savings are documented and verified

Request Analysis

Your verified number, in 48 hours.

Share what you know — estimates are fine. We return a documented savings analysis specific to your population and medications. No commitment, no contract, no follow-up pressure.

Specialty medications in your plan

List what you know of — name, members on it, and current monthly cost per member. Best estimates are fine; we verify everything in the analysis.

1
2

No commitment · no contract · your data is used only to build your analysis

Request received.

Your custom savings analysis will arrive at the email you provided within 48 hours.
Questions in the meantime? info@sigmaglobalinc.com